Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jun 1:14:1164756.
doi: 10.3389/fneur.2023.1164756. eCollection 2023.

Uric acid and neurological disease: a narrative review

Naoyuki Otani  1 , Eisei Hoshiyama #  2 , Motoshi Ouchi #  3 , Hidehiro Takekawa  2   4 , Keisuke Suzuki  2
Affiliations
Review

Uric acid and neurological disease: a narrative review

Naoyuki Otani et al. Front Neurol. .

Abstract

Hyperuricemia often accompanies hypertension, diabetes, dyslipidemia, metabolic syndrome, and chronic renal disease; it is also closely related to cardiovascular disease. Moreover, several epidemiological studies have linked hyperuricemia and ischemic stroke. However, uric acid may also have neuroprotective effects because of its antioxidant properties. An association between low uric acid levels and neurodegenerative diseases has been suggested, which may be attributed to diminished neuroprotective effects as a result of reduced uric acid. This review will focus on the relationship between uric acid and various neurological diseases including stroke, neuroimmune diseases, and neurodegenerative diseases. When considering both the risk and pathogenesis of neurological diseases, it is important to consider the conflicting dual nature of uric acid as both a vascular risk factor and a neuroprotective factor. This dual nature of uric acid is important because it may help to elucidate the biological role of uric acid in various neurological diseases and provide new insights into the etiology and treatment of these diseases.

Keywords: hyperuricemia; neurodegenerative disease; neurological disease; stroke; uric acid.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Role of uric acid in oxidative stress and its antioxidant properties. Uric acid has a dual nature, with both antioxidant and pro-oxidant effects, in neurological diseases. NO, nitric oxide; SOD, superoxide dismutase; ROS, radical oxygen species; ONOO−, peroxynitrite; RAAS, renin–angiotensin–aldosterone system; NADPH, nicotinamide adenine dinucleotide phosphate.
See this image and copyright information in PMC

References

    1. Japanese Society of Gout and Nucleic Acid Metabolism . Japanese Guideline for the Management of Hyperuricemia and Gout. 3rd edn. Tokyo, SHINDAN TO CHIRYO SHA, Inc (2018). p. 18–23.
    1. Johnson RJ. I Why focus on uric acid? Curr Med Res Opin. (2015) 8:14181. 10.1185/03007995.2015.1087979 - DOI - PubMed
    1. Otani N, Ouchi M, Misawa K, Hisatome I, Anzai N. Hypouricemia and urate transporters. Biomedicines. (2022) 10:652. 10.3390/biomedicines10030652 - DOI - PMC - PubMed
    1. Crotty GF, Ascherio A, Schwarzschild MA. Targeting urate to reduce oxidative stress in Parkinson disease. Exp Neurol. (2017) 298:210–24. 10.1016/j.expneurol.2017.06.017 - DOI - PMC - PubMed
    1. Gersch C, Palii SP, Imaram W, Kim KM, Karumanchi SA, Angerhofer A, et al. . Reactions of peroxynitrite with uric acid: formation of reactive intermediates, alkylated products and triuret, and in vivo production of triuret under conditions of oxidative stress. Nucleosides Nucleotides Nucleic Acids. (2009) 28:118–49. 10.1080/15257770902736400 - DOI - PMC - PubMed

LinkOut - more resources